Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Factors for Effectiveness of Aromatase Inhibitor (Letrozole) Therapy
2008-004874-42Phase 4Completed
- Sponsor
- Institut für Frauengesundheit
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of letrozole in breast cancer, sponsored by Institut für Frauengesundheit. Primary endpoint: Biomaterial collection and pharmacogenetic analysis. Started Dec 2008; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-004874-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004874-42.